Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity"

Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01937-20. doi: 10.1128/AAC.01937-20. Print 2020 Nov 17.

Minh Patrick Lê^{1

2}, Christine Le Beller³, Quentin Le Hingrat^{4

5}, Pierre Jaquet⁶, Paul-Henri Wicky⁷, Vincent Bunel⁷, Laurent Massias^{8

5}, Benoit Visseaux^{4

5}, Jonathan Messika⁷, Diane Descamps^{4

5}, Hervé Mal⁷, Jean-François Timsit^{5

6}, Gilles Peytavin^{8

5}

¹ AP-HP, Bichat Claude Bernard Hospital, Pharmacology-Toxicology Department, Paris, France [email protected].
² INSERM, UMRS-1144, Université de Paris, Paris, France.
³ AP-HP, Hôpital Européen Georges Pompidou, Centre Régional de Pharmacovigilance, Paris, France.
⁴ AP-HP, Bichat Claude Bernard Hospital, Virology Department, Paris, France.
⁵ IAME, INSERM, UMRS1137, Université de Paris, Paris, France.
⁶ AP-HP, Bichat Claude Bernard Hospital, Medical and Infectious Diseases ICU (MI2), Paris, France.
⁷ AP-HP, Bichat Claude Bernard Hospital, Pneumology B and Lung Transplant Department, INSERM 1152, Paris Transplant Group, Paris, France.
⁸ AP-HP, Bichat Claude Bernard Hospital, Pharmacology-Toxicology Department, Paris, France.

No abstract available

Publication types